ArticleNPJ precision oncology2026

First-in-human study of FLT3 CAR-T cell therapy for relapsed acute myeloid leukemia.

Xiaojin Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.